M. J. OʼConnell

4.9k citations

31 papers · 3.0k indexed · 1 hit paper · h-index 15

Impact in

Oncology top 1%
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Surgical Treatments
- Colorectal Cancer Screening and Detection
- Cancer Treatment and Pharmacology
Pathology and Forensic Medicine top 1%
- Genetic factors in colorectal cancer

Papers in

Oncology 26
- Colorectal Cancer Treatments and Studies 19
- Colorectal Cancer Surgical Treatments 11
- Colorectal Cancer Screening and Detection 6
- Cancer Treatment and Pharmacology 6
Pathology and Forensic Medicine 13
- Genetic factors in colorectal cancer 9
- Lymphoma Diagnosis and Treatment 4

Co-authors: Harry S. Wieand J A Mailliard James E. Krook Michael A. Poon Loren K. Tschetter C G Moertel John A. Laurie Michael Kahn
Journals: Journal of Clinical Oncology (14 papers)JNCI Journal of the National Cancer Institute (2 papers)British Journal of Cancer (2 papers)Seminars in Oncology (1 paper)British Journal of Anaesthesia (1 paper)
Partner nations: United States Canada United Kingdom

In The Last Decade

M. J. OʼConnell

30 papers receiving 2.9k citations

Hit Papers

align trajectories log scale

Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma. 1989 · 725 citations

Peers

Countries citing papers authored by M. J. OʼConnell

Since Specialization

Citations

This map shows the geographic impact of M. J. OʼConnell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. J. OʼConnell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. J. OʼConnell more than expected).

Fields of papers citing papers by M. J. OʼConnell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. J. OʼConnell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. J. OʼConnell. The network helps show where M. J. OʼConnell may publish in the future.

Co-authors

The 25 scholars most cited alongside M. J. OʼConnell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with M. J. OʼConnell Line = papers co-authored together M. J. OʼConnell links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Impact of age and medical comorbidity on adjuvant treatment outcomes for stage III colon cancer: a pooled analysis of individual patient data from four randomized, controlled trials Annals of Oncology ·Daniel G. Haller, M. J. OʼConnell, Thomas H. Cartwright, Chris Twelves, Edward McKenna, Weijing Sun, Muhammad Wasif Saif, Renato Ramos Silva, Greg Yothers, Hans‐Joachim Schmoll	2015	84
2	Innovative estimation of survival using log-normal survival modelling on ACCENT database British Journal of Cancer ·(unknown), Judith‐Anne W. Chapman, Chris J. O’Callaghan, Nianping Hu, Keyue Ding, Greg Yothers, Paul J. Catalano, Qian Shi, Richard Gray, M. J. OʼConnell, Daniel J. Sargent	2013	17
3	Prognostic effect of activated EGFR expression in human colon carcinomas: comparison with EGFR status British Journal of Cancer ·Rafaela L. Rego, Nathan R. Foster, Thomas C. Smyrk, M. H. Le, M. J. OʼConnell, Daniel J. Sargent, Harold E. Windschitl, Frank A. Sinicrope	2009	83
4	Durable improvement in disease-free survival (DFS) and overall survival (OS) for stage II or III colon cancer treated with leucovorin-modulated fluorouracil (FL): 10-year follow-up of National Surgical Adjuvant Breast and Bowel Project (NSABP) protocol C-03 Journal of Clinical Oncology ·M. J. OʼConnell, Norman Wolmark, Greg Yothers, Sarah R. Haile, Linda H. Colangelo, Nicholas J. Petrelli	2005	7
5	North Central Cancer Treatment Group[mdash ]Mayo Clinic trials in colon cancer Seminars in Oncology ·M. J. OʼConnell	2001	1
6	Microsatellite Instability and 8p Allelic Imbalance in Stage B2 and C Colorectal Cancers JNCI Journal of the National Cancer Institute ·Kevin C. Halling, Amy J. French, Shannon K. McDonnell, Lawrence J. Burgart, Daniel J. Schaid, Bryan J. Peterson, Laurie L. Moon‐Tasson, M. R. Mahoney, Daniel J. Sargent, M. J. OʼConnell, T.E. Witzig, Gist H. Farr, Richard M. Goldberg, Stephen N. Thibodeau	1999	307
7	Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer. Journal of Clinical Oncology ·M. J. OʼConnell, John A. Laurie, Michael Kahn, (unknown), Charles Erlichman, Lois E. Shepherd, C G Moertel, Walter Kocha, Richard Pazdur, Harry S. Wieand, Joseph Rubin, Allen M. Vukov, J H Donohue, James E. Krook, A Figueredo	1998	289
8	Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer. Journal of Clinical Oncology ·M. J. OʼConnell, J A Mailliard, Michael Kahn, J. S. Macdonald, Daniel G. Haller, Robert J. Mayer, Harry S. Wieand	1997	447
9	Adjuvant postoperative fluorouracil-modulated chemotherapy combined with pelvic radiation therapy for rectal cancer: initial results of intergroup 0114. Journal of Clinical Oncology ·Joel E. Tepper, M. J. OʼConnell, Gina R. Petroni, Donna Hollis, E. M. Cooke, Al B. Benson, B. Cummings, Leonard L. Gunderson, J. S. Macdonald, James A. Martenson	1997	176
10	Aggressive Chemotherapy in the Treatment of Burkitt's and Non-BurKitt's Undifferentiated Lymphoma Leukemia & lymphoma ·J. J. Mazza, John Hines, Janet W. Andersen, Richard S. Neiman, Ritse M. Mann, M. M. Oken, M. J. OʼConnell	1995	5
11	An Aggressive High Dose Cyclophosphamide and Prednisone Regimen for Advanced Multiple Myeloma Leukemia & lymphoma ·Raymond E. Lenhard, Michael J. Daniels, M. M. Oken, John H. Glick, David S. Ettinger, Leslie A. Kalish, M. J. OʼConnell	1994	6
12	Phase II trial of pentostatin in refractory lymphomas and cutaneous T-cell disease. Journal of Clinical Oncology ·F J Cummings, Ki Wook Kim, Richard S. Neiman, Di Wu, M. M. Oken, Sigmund A. Weitzman, Risa B. Mann, M. J. OʼConnell	1991	71
13	AN EARLY MARKER OF HYPEROXIC LUNG INJURY IN THE RAT AND ITS PHARMACOLOGICAL MODULATION British Journal of Anaesthesia ·M. J. OʼConnell, Popoola Temitope Olubukola, J. F. Nunn	1991	9
14	Biochemical modulation of fluorouracil with leucovorin: confirmatory evidence of improved therapeutic efficacy in advanced colorectal cancer. Journal of Clinical Oncology ·Michael A. Poon, M. J. OʼConnell, Harry S. Wieand, James E. Krook, James B. Gerstner, Loren K. Tschetter, Ralph Levitt, Carl G. Kardinal, J A Mailliard	1991	298
15	Pentostatin induces durable remissions in hairy cell leukemia. Journal of Clinical Oncology ·Peter A. Cassileth, Brigitte Cheuvart, A. S. D. Spiers, David P. Harrington, F J Cummings, Richard S. Neiman, John M. Bennett, M. J. OʼConnell	1991	83
16	Status of Adjuvant Therapy for Colorectal Cancer JNCI Journal of the National Cancer Institute ·R. John Mayer, M. J. OʼConnell, Joel E. Tepper, Norman Wolmark	1989	22
17	Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma. Journal of Clinical Oncology ·Michael A. Poon, M. J. OʼConnell, C G Moertel, Harry S. Wieand, Stephen A. Cullinan, Lloyd K. Everson, James E. Krook, J A Mailliard, John A. Laurie, Loren K. Tschetter Hit paper breakdown →	1989	725
18	Clinical Trial of Cisplatin and Intensive Course 5-Fluorouracil for the Treatment of Advanced Colorectal Cancer American Journal of Clinical Oncology ·M. J. OʼConnell, C G Moertel, Larry K. Kvols, R. G. Hahn, Joseph Rubin	1986	11
19	A phase II study of the combination, 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and N-(phosphonacetyl)-L-aspartate (PALA), in patients with advanced large bowel cancer American Journal of Clinical Oncology ·Joseph Rubin, Allan J. Schutt, M. J. OʼConnell, M. A. Gertz, V Palanghi	1984	2
20	Pilot study of PALA and 5-FU in patients with advanced cancer. PubMed ·M. J. OʼConnell, Garth Powis, Jonah Rubin, C G Moertel	1982	14

About M. J. OʼConnell

M. J. OʼConnell is a scholar working on Oncology, Pathology and Forensic Medicine, Genetics, Pulmonary and Respiratory Medicine and Pharmacy, having authored 31 papers that have together received 3.0k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (19 papers), Colorectal Cancer Surgical Treatments (11 papers), Genetic factors in colorectal cancer (9 papers), Colorectal Cancer Screening and Detection (6 papers), Cancer Treatment and Pharmacology (6 papers), Colorectal and Anal Carcinomas (6 papers), Gastric Cancer Management and Outcomes (5 papers) and Lymphoma Diagnosis and Treatment (4 papers). The work is most often cited by research in Oncology (2.5k citations), Pathology and Forensic Medicine (989 citations), Hepatology (235 citations), Pulmonary and Respiratory Medicine (809 citations) and Surgery (881 citations). M. J. OʼConnell has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Harry S. Wieand, J A Mailliard, James E. Krook, Michael A. Poon, Loren K. Tschetter, C G Moertel, John A. Laurie, Michael Kahn, J. S. Macdonald and Stephen A. Cullinan. Their work appears in journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute, British Journal of Cancer, Seminars in Oncology and British Journal of Anaesthesia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact